À retenir
A narrative review suggests that dietary polyphenols may reduce markers of exercise-induced muscle damage, calm inflammation and speed recovery of strength, with plausible links to muscle aging. Most human data come from young or healthy people and the search was non-systematic, so benefits for older adults and sarcopenia remain unproven.
Study design
Article de recherche
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Polyphenols, plant compounds found in foods like berries, tea and cocoa, influence oxidative stress, inflammation and mitochondrial function. The authors asked whether the evidence on exercise recovery could help explain, and later test, ways to slow muscle aging and sarcopenia (age-related muscle loss).
Population et méthode
Narrative review based on a structured but non-systematic literature search, combining human intervention trials, preclinical studies and mechanistic research on polyphenols, exercise adaptation, muscle recovery and muscle aging. Findings were synthesized narratively with an emphasis on shared physiological pathways and functional outcomes. The abstract does not report the number of studies, specific polyphenols, doses or any pooled estimates.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Human intervention studies suggest polyphenol intake may reduce biomarkers of exercise-induced muscle damage, modulate inflammatory responses and speed recovery of muscle strength and functional performance.
- 2Mechanistic evidence points to redox balance (oxidative stress control), mitochondrial regulation and inflammatory signaling as the central pathways.
- 3Clinical data in older people remain limited, though the recovery pathways overlap with those implicated in age-related muscle decline.
- 4The authors propose a framework to guide future targeted trials in older and clinical populations.
Limites et incertitude
- 1The literature search was non-systematic, so relevant studies may be missing or selectively included.
- 2Part of the evidence is preclinical or mechanistic, which cannot be directly applied to people or to doses.
- 3Most human studies involve young or metabolically healthy people, which limits translation to older adults, the group most at risk of sarcopenia.
- 4This reading is based on the abstract only.
Mise en perspective
A diet rich in colourful plants is a sensible habit for general health, and this review gives a biologically plausible reason to expect it may help recovery. It does not show that polyphenol supplements build muscle or prevent sarcopenia, or that they are safe at any dose, so discuss supplements with a clinician or dietitian, especially if you are older or take medicines.
Vos données
If you experiment with diet changes, track a few things consistently: perceived soreness, strength on a repeatable lift or test, and training load, and compare several weeks rather than single sessions. Wearable recovery or readiness scores are rough guides, not measures of muscle damage.
Comprendre ce type de preuve
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Introduction
The biological effects of dietary polyphenols have gained increasing attention due to their roles in regulating oxidative stress, inflammatory processes, and mitochondrial function. Human studies suggest that polyphenol intake may support aspects of post-exercise recovery, neuromuscular function, and selected aspects of physical performance. However, most investigations have been conducted in young or metabolically healthy populations, limiting direct clinical translation to older adults.
Objective
This narrative review aims to synthesize current mechanistic and human evidence on the physiological and recovery-related effects of dietary polyphenols in the context of exercise adaptation and skeletal muscle function, and to examine their potential relevance to muscle aging and sarcopenia.
Methods
A structured, non-systematic literature search was conducted to integrate findings from human intervention trials, preclinical studies, and mechanistic research addressing polyphenols, exercise adaptation, muscle recovery, and muscle aging. Evidence was synthesized narratively with emphasis on shared physiological pathways and functional outcomes.
Results
Human intervention studies suggest that polyphenol intake may attenuate biomarkers of exercise-induced muscle damage, modulate inflammatory responses, and accelerate recovery of muscle strength and functional performance. Mechanistic evidence supports the involvement of redox homeostasis, mitochondrial regulation, and inflammatory signaling as central mediators of these effects. While clinical data in older populations remain limited, converging evidence suggests biological overlap between recovery-related pathways and mechanisms implicated in age-related muscle decline.
Conclusions
Current evidence is consistent with a biologically plausible role for polyphenols in modulating exercise-related physiological and recovery processes. By aligning recovery-focused evidence with pathways central to muscle aging, this review proposes a translational framework that may inform the design of future targeted clinical trials in older and clinical populations.
Sources et attribution
Physiological and Recovery Responses to Dietary Polyphenols in the Context of Exercise: Relevance for Muscle Aging and Sarcopenia.
Fazekas-Pongor V, Major D, Varga JT, Lehoczki A, Varga P, Jarecsny T, Lipécz Á, Csípő T, Szappanos Á, Matiscsák A, Fekete M.
Nutrients · 2026-02-27
DOI: 10.3390/nu18050788 ↗PubMed · 41829959 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

